Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: A single‐center prospective longitudinal study
Ganeem K. Juneja, Matthew Castelo, Calvin H. Yeh, Samantha E. Cerroni, Bettina E. Hansen, James E. Chessum, Joel O. Abraham, Erblin Cani, Dhruva J. Dwivedi, Douglas D. Fraser, Marat Slessarev, Claudio M. Martin, Scott McGilvray, Peter L. Gross, Patricia C. Liaw, Jeffrey I. Weitz, Paul Y. Kim
Topics & Concepts
FibrinolysisCritically illCoronavirus disease 2019 (COVID-19)MedicineCoagulation2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Prospective cohort studyCritical illnessSingle CenterIntensive care medicineInternal medicineCardiologyVirologyDiseaseOutbreakInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSepsis Diagnosis and TreatmentHeparin-Induced Thrombocytopenia and Thrombosis